NCT01760187View on ClinicalTrials.gov

Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 7, 2012

Primary Completion Date

June 3, 2013

Study Completion Date

June 3, 2013

Conditions
Healthy Volunteer
Interventions
DRUG

lomitapide

Trial Locations (1)

CR7 7YE

Richmond Pharmacology Ltd, Croydon

Sponsors
All Listed Sponsors
collaborator

Richmond Pharmacology Limited

INDUSTRY

lead

Aegerion Pharmaceuticals, Inc.

INDUSTRY

NCT01760187 - Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C | Biotech Hunter | Biotech Hunter